(Q68888665)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

author name string

F J Primus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

T K Pendurthi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

P Hutzell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

S Kashmiri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

D C Slavin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

R Callahan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J Schlom

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

349-357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01741406

28 September 2019

exact match

0 references

cites work

IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells

1 reference

12 December 2020

Tumor cell killing by freshly isolated peripheral blood monocytes

1 reference

12 December 2020

Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein

1 reference

12 December 2020

Current status of antitumor therapy with monoclonal antibodies

1 reference

12 December 2020

Effect of combined therapy with lymphokine-activated killer cells, interleukin 2 and specific monoclonal antibody on established B16 melanoma lung metastases.

1 reference

12 December 2020

Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells

1 reference

12 December 2020

Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3.

1 reference

12 December 2020

Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice

1 reference

12 December 2020

Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells

1 reference

12 December 2020

Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies

1 reference

12 December 2020

Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma

1 reference

12 December 2020

Effect of anti-B16 melanoma monoclonal antibody on established murine B16 melanoma liver metastases

1 reference

12 December 2020

Expression in COS cells of a mouse-human chimaeric B72.3 antibody

1 reference

12 December 2020

Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen

1 reference

12 December 2020

Immunoglobulin G: functional sites

1 reference

12 December 2020

Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity

1 reference

12 December 2020

A spectrum of monoclonal antibodies reactive with human mammary tumor cells

1 reference

12 December 2020

Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3.

1 reference

12 December 2020

Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth.

1 reference

12 December 2020

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

1 reference

12 December 2020

Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2.

1 reference

12 December 2020

Monoclonal anticolon carcinoma antibodies in complement‐dependent cytotoxicity

1 reference

12 December 2020

Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3.

1 reference

12 December 2020

Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells

1 reference

12 December 2020

Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment

1 reference

12 December 2020

Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapy

1 reference

12 December 2020

Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity

1 reference

12 December 2020

A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer: preliminary report

1 reference

12 December 2020

Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).

1 reference

12 December 2020

Production of a mouse-human chimeric monoclonal antibody to CD20 with potent Fc-dependent biologic activity.

1 reference

12 December 2020

Antitumor antibodies for therapy

1 reference

12 December 2020

Augmentation of lymphokine-activated killer cell cytotoxicity by monoclonal antibodies against human small cell lung carcinoma.

1 reference

12 December 2020

A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epithelium

1 reference

12 December 2020

Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions

1 reference

12 December 2020

Specific enhancement of the therapeutic effect of anti-idiotype antibodies on a murine B cell lymphoma by IL-2

1 reference

12 December 2020

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells

1 reference

12 December 2020

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

1 reference

12 December 2020

Phase I Trial of Multiple Large Doses of Murine Monoclonal Antibody CO17-1A. I. Clinical Aspects1

1 reference

12 December 2020

Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues

1 reference

12 December 2020

Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin

1 reference

12 December 2020

Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.

1 reference

12 December 2020

Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity

1 reference

12 December 2020

Mouse/human chimeric antibodies to a tumor-associated antigen: biologic activity of the four human IgG subclasses

1 reference

12 December 2020

Antibody-mediated killing of human tumor cells by attached effector cells

1 reference

12 December 2020

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma

1 reference

12 December 2020

Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.

1 reference

12 December 2020

Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72)

1 reference

12 December 2020

Reshaping human antibodies for therapy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01741406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386980%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference